相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis
Ya-Long Feng et al.
MEDICINAL RESEARCH REVIEWS (2020)
Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities
Meghan J. Chenoweth et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer
Chao-Yang Lai et al.
CANCERS (2020)
The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment
Casimiro Gerarduzzi et al.
CANCER RESEARCH (2020)
Twist1 induces chromosomal instability (CIN) in colorectal cancer cells
Maithilee Khot et al.
HUMAN MOLECULAR GENETICS (2020)
Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
Prathibha Kirave et al.
Oncotarget (2020)
Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression
Olaia Martinez-Iglesias et al.
CANCERS (2020)
Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
Sylvie Brassart-Pasco et al.
FRONTIERS IN ONCOLOGY (2020)
Permissive State of EMT: The Role of Immune Cell Compartment
Vita Fedele et al.
FRONTIERS IN ONCOLOGY (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations
Monica M. Arroyo et al.
BIOMOLECULES (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma
Peng-Fei Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
Chien-Hui Weng et al.
ONCOGENE (2019)
Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
Zachary A. Yochum et al.
ONCOGENE (2019)
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential
Dongsong Nie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
被撤回的出版物: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer (Retracted article. See vol. 21, 2022)
Tong Liu et al.
MOLECULAR CANCER (2019)
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
Ningning Li et al.
ONCOGENESIS (2019)
Therapy resistance mediated by exosomes
Teresa Bernadette Steinbichler et al.
MOLECULAR CANCER (2019)
The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
Dong-ming Wu et al.
CELL DEATH & DISEASE (2019)
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Sudha Suriyamurthy et al.
CANCERS (2019)
MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells
Mingqi Wang et al.
GENE (2019)
TGF--Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Yang Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TGFβ-induced cytoskeletal remodeling mediates elevation of cell stiffness and invasiveness in NSCLC
E. Gladilin et al.
SCIENTIFIC REPORTS (2019)
Pharmacogenomics in Practice
Liewei Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
Xiao-Guang Yang et al.
FRONTIERS IN ONCOLOGY (2019)
Extracellular Matrix Alterations in Metastatic Processes
Mayra Paolillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells
Li Jing et al.
SCIENTIFIC REPORTS (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel-sensitive cells via exosomal delivery of miR-155-5p
Mei Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy
Amirhossein Ahmadi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells
Kei Namba et al.
MOLECULAR CANCER RESEARCH (2019)
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
SphK1 functions downstream of IGF-1 to modulate IGF-1-induced EMT, migration and paclitaxel resistance of A549 cells: A preliminary in vitro study
Xingping Wu et al.
JOURNAL OF CANCER (2019)
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells
Simona Punzi et al.
BREAST CANCER RESEARCH (2019)
KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
Bo Hu et al.
JOURNAL OF CANCER (2019)
Controversies around epithelial-mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams et al.
NATURE REVIEWS CANCER (2019)
Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling
Yanmei Yi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGF alpha
Higinio Dopeso et al.
CANCER RESEARCH (2018)
Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
David van Dijk et al.
CELL (2018)
E3 ubiquitin ligase Hakai regulates cell growth and invasion, and increases the chemosensitivity to cisplatin in non-small-cell lung cancer cells
Zi Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
Hsi-Wen Yeh et al.
NATURE CELL BIOLOGY (2018)
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
Jinnan Yue et al.
ONCOGENE (2018)
CAFs enhance paclitaxel resistance by inducing EMT through the IL-6/JAK2/STAT3 pathway
Linlin Wang et al.
ONCOLOGY REPORTS (2018)
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
Joel P. Joseph et al.
ORAL ONCOLOGY (2018)
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
Tian Fang et al.
NATURE COMMUNICATIONS (2018)
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer
Virginia Murillo-Garzon et al.
NATURE COMMUNICATIONS (2018)
Hakai overexpression effectively induces tumour progression and metastasis in vivo
Raquel Castosa et al.
SCIENTIFIC REPORTS (2018)
Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
Young Kwang Chae et al.
SCIENTIFIC REPORTS (2018)
The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation
Stephanie Duhamel et al.
CELL REPORTS (2018)
Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer
Yuichiro Okumura et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
Long Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Identification of the tumour transition states occurring during EMT
Ievgenia Pastushenko et al.
NATURE (2018)
A SIRT1-centered circuitry regulates breast cancer stemness and metastasis
Lei Shi et al.
ONCOGENE (2018)
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
Jonathan T. Lei et al.
CELL REPORTS (2018)
The Yin and Yang of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese et al.
CANCERS (2018)
FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells
Yuwen He et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer
Soon-Ki Hong et al.
MOLECULAR CANCER (2018)
Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
Xin Wu et al.
CELL DEATH & DISEASE (2018)
Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability
Toni Celia-Terrassa et al.
NATURE COMMUNICATIONS (2018)
A history of exploring cancer in context
Shelly Maman et al.
NATURE REVIEWS CANCER (2018)
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
Kyung-A Song et al.
CLINICAL CANCER RESEARCH (2018)
Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon
George Tzanakakis et al.
DEVELOPMENTAL DYNAMICS (2018)
The relationship between platinum drug resistance and epithelial-mesenchymal transition
Anamaria Brozovic
ARCHIVES OF TOXICOLOGY (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells
Emilia Wiechec et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling
Ying Xiong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Jacob M. Smigiel et al.
MOLECULAR CANCER RESEARCH (2017)
A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer
Momeneh Foroutan et al.
MOLECULAR CANCER RESEARCH (2017)
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez-Carmona et al.
MOLECULAR ONCOLOGY (2017)
New insights into the role of EMT in tumor immune escape
Stephane Terry et al.
MOLECULAR ONCOLOGY (2017)
Upholding a role for EMT in breast cancer metastasis
Xin Ye et al.
NATURE (2017)
Upholding a role for EMT in pancreatic cancer metastasis
Nicole M. Aiello et al.
NATURE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
Shihua Chu et al.
ONCOLOGY REPORTS (2017)
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
Brian Bierie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Charli Dominguez et al.
SEMINARS IN CANCER BIOLOGY (2017)
Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition
Liang Mao et al.
ONCOLOGY LETTERS (2017)
A step-by-step microRNA guide to cancer development and metastasis
Georgios S. Markopoulos et al.
CELLULAR ONCOLOGY (2017)
ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis
Sivan Izraely et al.
ONCOTARGET (2017)
Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors
Nancy K. Gillis et al.
ONCOTARGET (2017)
Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
Xiao-Long Li et al.
SCIENTIFIC REPORTS (2017)
Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition
Wenzhe Song et al.
FRONTIERS IN IMMUNOLOGY (2017)
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?
Cristina Raimondi et al.
ONCOIMMUNOLOGY (2017)
Exploring the Role of RGD-Recognizing Integrins in Cancer
Markus Nieberler et al.
CANCERS (2017)
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells
An-Fu Lee et al.
PLOS ONE (2017)
miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
Hidekazu Hiramoto et al.
SCIENTIFIC REPORTS (2017)
miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma
Qiaofen Fu et al.
CLINICAL CANCER RESEARCH (2017)
Natural killer cells and tumor metastasis
Hwan Hee Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Martin Turcotte et al.
CANCER RESEARCH (2017)
Hypoxic pathobiology of breast cancer metastasis
Luana Schito et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition
Reem Malek et al.
CELLS TISSUES ORGANS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer
Sarah K. Martin et al.
CANCER RESEARCH (2016)
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena P. Mak et al.
CLINICAL CANCER RESEARCH (2016)
HIF-1 at the crossroads of hypoxia, inflammation, and cancer
Kuppusamy Balamurugan
INTERNATIONAL JOURNAL OF CANCER (2016)
CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
Y-C Wu et al.
ONCOGENE (2016)
Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells
Ichiro Ota et al.
ONCOLOGY REPORTS (2016)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
EMT, cell plasticity and metastasis
Christine L. Chaffer et al.
CANCER AND METASTASIS REVIEWS (2016)
The pharmacogenomics of drug resistance to protein kinase inhibitors
Nancy K. Gillis et al.
DRUG RESISTANCE UPDATES (2016)
The bad seed: Cancer stem cells in tumor development and resistance
Elle Koren et al.
DRUG RESISTANCE UPDATES (2016)
Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression
Peter J. Chockley et al.
JOURNAL OF IMMUNOLOGY (2016)
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
Yasushi Shintani et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer
C-W Chien et al.
ONCOGENE (2016)
F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check
Victor M. Diaz et al.
SEMINARS IN CANCER BIOLOGY (2016)
Signaling Receptors for TGF-β Family Members
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
A new dimension in drug discovery: reversing epithelial-mesenchymal transition (EMT)
Ruby Yun-Ju Huang et al.
CELL DEATH & DISEASE (2016)
MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells
Jingyi Yu et al.
NATURE COMMUNICATIONS (2016)
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
Chan-Young Ock et al.
ONCOTARGET (2016)
miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
Qing-yong Chen et al.
ONCOTARGET (2016)
EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells
Jinkyoung Kim et al.
ONCOTARGET (2016)
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
Sabina Sangaletti et al.
CELL REPORTS (2016)
Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration
Christine Mayer et al.
JOURNAL OF CANCER (2016)
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Claudia Cantoni et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma
Adrian Biddle et al.
EBIOMEDICINE (2016)
MicroRNA Regulation of Epithelial to Mesenchymal Transition
Mohammed L. Abba et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Signal Transduction Pathways of EMT Induced by TGF-, SHH, and WNT and Their Crosstalks
Jingyu Zhang et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
Peixin Dong et al.
SCIENTIFIC REPORTS (2016)
Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
Ryuji Matsumoto et al.
SCIENTIFIC REPORTS (2016)
Re-Evaluating Clonal Dominance in Cancer Evolution
Rebecca A. Burrell et al.
TRENDS IN CANCER (2016)
Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment
Alessandro Poggi et al.
VACCINES (2016)
Multidrug Resistance Proteins (MRPs) and Cancer Therapy
Yun-Kai Zhang et al.
AAPS JOURNAL (2015)
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
M. Ricciardi et al.
BRITISH JOURNAL OF CANCER (2015)
Clinical implications of epithelial cell plasticity in cancer progression
Luis A. Aparicio et al.
CANCER LETTERS (2015)
A Systematic Approach to Defining the microRNA Landscape in Metastasis
Giridhar Mudduluru et al.
CANCER RESEARCH (2015)
IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization
Aude I. Segaliny et al.
CYTOKINE (2015)
Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer
Masayoshi Toge et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
Anamaria Brozovic et al.
MOLECULAR ONCOLOGY (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Pharmacogenomics in the clinic
Mary V. Relling et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Xin Ye et al.
TRENDS IN CELL BIOLOGY (2015)
Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT
Eugenio Zoni et al.
JOURNAL OF ONCOLOGY (2015)
Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer
Q. H. Miow et al.
ONCOGENE (2015)
INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform
Xiao Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Breast cancer stem cells, EMT and therapeutic targets
Srishti Kotiyal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
Y. Yu et al.
BRITISH JOURNAL OF CANCER (2014)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
The role played by the microenvironment in site-specific metastasis
Anat Klein-Goldberg et al.
CANCER LETTERS (2014)
Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression
Vivek Kumar Mishra et al.
CELL AND TISSUE RESEARCH (2014)
Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1 alpha in Pancreatic Cancer Cells
Rui Wang et al.
CURRENT CANCER DRUG TARGETS (2014)
Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
Tuan Zea Tan et al.
EMBO MOLECULAR MEDICINE (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
MiR-134/487b/655 Cluster Regulates TGF-β-Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
Kazuhiro Kitamura et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Epithelial-to-Mesenchymal Transition Activates PERK-eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress
Yu-xiong Feng et al.
CANCER DISCOVERY (2014)
Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition
Stephan Lindsey et al.
FRONTIERS IN ONCOLOGY (2014)
Identification of Two Distinct Carcinoma-Associated Fibroblast Subtypes with Differential Tumor-Promoting Abilities in Oral Squamous Cell Carcinoma
Daniela Elena Costea et al.
CANCER RESEARCH (2013)
Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition
Luis A. Aparicio et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
Hongping Xia et al.
HEPATOLOGY (2013)
Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6
Abulimiti Abulaiti et al.
LUNG CANCER (2013)
High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
Xiao Tian et al.
NATURE (2013)
Tumor and its microenvironment: A synergistic interplay
Veronica Catalano et al.
SEMINARS IN CANCER BIOLOGY (2013)
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
Alexandria M. Haslehurst et al.
BMC CANCER (2012)
MicroRNA control of epithelial-mesenchymal transition and metastasis
Jinsong Zhang et al.
CANCER AND METASTASIS REVIEWS (2012)
Biological influence of Hakai in cancer: a 10-year review
Luis A. Aparicio et al.
CANCER AND METASTASIS REVIEWS (2012)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
Tumor microenvironment regulates epithelial-mesenchymal transitions in metastasis
Dingcheng Gao et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
LOXL2 in epithelial cell plasticity and tumor progression
Amparo Cano et al.
FUTURE ONCOLOGY (2012)
Pharmacogenomics in clinical practice and drug development
Andrew R. Harper et al.
NATURE BIOTECHNOLOGY (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
Benjamin Toh et al.
PLOS BIOLOGY (2011)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
Zhiwei Wang et al.
DRUG RESISTANCE UPDATES (2010)
Implication of microRNAs in drug resistance for designing novel cancer therapy
Fazlul H. Sarkar et al.
DRUG RESISTANCE UPDATES (2010)
Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms
Bryan L. Copple
LIVER INTERNATIONAL (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
Pharmacogenetics and Pharmacogenomics of Anticancer Agents
R. Stephanie Huang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-induced EMT of Cancer Cells
Chie Kudo-Saito et al.
CANCER CELL (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Novel Roles of Hakai in Cell Proliferation and Oncogenesis
Angelica Figueroa et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition
Theresa Vincent et al.
NATURE CELL BIOLOGY (2009)
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
A. Emre Sayan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
Nawneet K. Kurrey et al.
STEM CELLS (2009)
Yin-yang activities and vicious cycles in the tumor microenvironment
Isaac P. Witz
CANCER RESEARCH (2008)
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
Michele Sabbah et al.
DRUG RESISTANCE UPDATES (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells
David Olmeda et al.
CANCER RESEARCH (2007)
Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs
Xue-Qing Yu et al.
CURRENT DRUG METABOLISM (2007)
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Matt K. Lee et al.
EMBO JOURNAL (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Raf plus TGFβ-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin
E. Janda et al.
ONCOGENE (2006)
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
RL Yauch et al.
CLINICAL CANCER RESEARCH (2005)
Cancer pharmacogenomics: Powerful tools in cancer chemotherapy and drug development
W Lee et al.
ONCOLOGIST (2005)
Drug resistance and the microenvironment: nature and nurture
PJ Morin
DRUG RESISTANCE UPDATES (2003)
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Y Fujita et al.
NATURE CELL BIOLOGY (2002)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
分享论文
